Anatomical characterization of hoof growth pattern in six Iranian sheep breeds and its possible implication for trimming recommendations

Tropical Animal Health and Production - The objective of this study was to compare hoof anatomy, hoof growth pattern, and hoof weight-bearing surface of six different Iranian sheep breeds to...     

Ergovaline does not alter the severity of ryegrass staggers induced by lolitrem B

AIM: To investigate a possible interaction between lolitrem B and ergovaline by comparing the incidence and severity of ryegrass staggers in sheep grazing ryegrass (Lolium perenne) containing lolitrem B or ryegrass containing both lolitrem B and ergovaline.

METHODS: Ninety lambs, aged approximately 6 months, were grazed on plots of perennial ryegrass infected with either AR98 endophyte (containing lolitrem B), standard endophyte (containing lolitrem B and ergovaline) or no endophyte, for up to 42 days from 2 February 2010. Ten lambs were grazed on three replicate plots per cultivar. Herbage samples were collected for alkaloid analysis and lambs were scored for ryegrass staggers (scores from 0–5) weekly during the study. Any animal which was scored ≥4 was removed from the study.

RESULTS: Concentrations of lolitrem B did not differ between AR98 and standard endophyte-infected pastures during the study period (p=0.26), and ergovaline was present only in standard endophyte pastures. Ryegrass staggers was observed in sheep grazing both the AR98 and standard endophyte plots, with median scores increasing in the third week of the study. Prior to the end of the 42-day grazing period, 22 and 17 animals were removed from the standard endophyte and AR98 plots, respectively, because their staggers scores were ≥4. The cumulative probability of lambs having scores ≥4 did not differ between animals grazing the two pasture types (p=0.41).

CONCLUSIONS AND CLINICAL RELEVANCE: There was no evidence for ergovaline increasing the severity of ryegrass staggers induced by lolitrem B. In situations where the severity of ryegrass staggers appears to be greater than that predicted on the basis of concentrations of lolitrem B, the presence of other tremorgenic alkaloids should be investigated.     

Organoclays for controlled release of the herbicide fenuron

Organoclays were assayed as matrices in which to associate herbicides, with the aim of decreasing product losses that could give rise to water contamination from agricultural activities. Fenuron was selected as model of a very mobile and highly water-soluble herbicide. Two different organoclays of high (A-HDT) and low (H-C18) reversible fenuron sorption were selected. Herbicide-organoclay complexes were prepared from the two organoclays and with two different fenuron contents (20 and 40 g AI kg-1) and two different mixing times, so as to form a series of weak and strong complexes. The release of fenuron from those complexes into water and water/soil suspensions gave values of T50 (time to release 50% of the fenuron content) ranging from 0.3 min to 2400 h. The total fenuron released in these closed systems ranged from 48 to 80% of the fenuron in the complex. The organoclay type (high or low sorptivity) had the greatest influence on fenuron release, followed by the strong or weak complex, suggesting that herbicide-organoclay interactions are the main factors controlling release. Soil column leaching experiments showed fenuron-organoclay complexes to be effective in reducing the peak herbicide concentration in the leachate to a half (6 microns) or a quarter (3 microns) of that obtained from the free technical compound (12 microns). Herbicide lost through leaching was reduced from 78% for the free technical fenuron to 50-30%, depending on the organoclay used as carrier and the strength of the complex. Bioassay with ryegrass showed that the weak fenuron/H-C18 complex (40 g AI kg-1) gave the same herbicidal activity as technical fenuron. The potential suitability of low-sorptive organoclays for conferring slow-release properties on the fenuron complex has been demonstrated.     

The Development, Clinical Signs and Economic Losses of Gastrointestinal Parasitism in Feeder Cattle on Irrigated and Non-irrigated Dikeland and Upland Pastures

Investigations were carried out over three grazing seasons with parasitized and treated (control) steers on irrigated and non-irrigated upland and dikeland pastures. The stocking rate in each paddock was adjusted by either adding or removing animals so as to maintain as uniform a sward and rate of grazing as possible. Animals were weighed on and off the pastures and fortnightly during the grazing seasons.

During the first grazing season clinically normal steers shedding low numbers of gastrointestinal worm eggs contaminated the parasite-free pastures sufficiently to give rise to large residual pasture infections and clinical parasitic gastroenteritis in grazing stock during the second grazing season. Worm burdens of 100,000 to 200,000 Ostertagia ostertagi and Cooperia oncophora were established in several steers showing marked clinical signs. In spite of treatments with high dosages of thiabendazole in attempts to keep worm burdens at a minimum, there was a slow but gradual buildup of pasture infections in the paddocks grazed by the control steers over the three year period.

During the second and third grazing seasons there were significant differences in the daily rate of gain between the parasitized and control animals on both upland and dikeland pastures. The parasitized groups of steers had daily rates of gain ranging from 0.29 to 0.80 pounds less than their comparable control groups.

Under Maritime conditions, irrigation did not have a consistent effect on weight gains and development of parasitism.

     

High incidence of abortions and congenital deformities of unknown aetiology in a beef herd

In 1980, 16 abortions or stillbirths occurred and 26 deformed calves were born in a beef herd of 115 Friesian cross Hereford cows mated to Charolais bulls. The deformities were principally arthrogryposes with contractures, particularly of the forelimbs, and various skull abnormalities. Following investigation it was considered highly unlikely that hereditary causes, infectious agents or a nutritional deficiency were responsible. The most likely cause was exposure to an unidentified teratogen early in pregnancy.     

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

The isolation of broadly neutralizing antibodies against influenza A viruses has been a long-sought goal for therapeutic approaches and vaccine design. Using a single-cell culture method for screening large numbers of human plasma cells, we isolated a neutralizing monoclonal antibody that recognized the hemagglutinin (HA) glycoprotein of all 16 subtypes and neutralized both group 1 and group 2 influenza A viruses. Passive transfer of this antibody conferred protection to mice and ferrets. Complexes with HAs from the group 1 H1 and the group 2 H3 subtypes analyzed by x-ray crystallography showed that the antibody bound to a conserved epitope in the F subdomain. This antibody may be used for passive protection and to inform vaccine design because of its broad specificity and neutralization potency.